Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1030469]Researchers: Prof Andrew Scott (Principal investigator) , A/Pr Paul Ramsland , Dr Fook Lee , Dr Ingrid Burvenich
Brief description Use of antibodies for cancer therapy, where a protein is made in the laboratory to recognize and act on cancer cells that have a target antigen, has emerged as an important therapeutic area in oncology. The lewis-y (Ley) antigen is found on more than 70% of epithelial cancers and the A33 antigen is found on colon cancers. We have developed antibodies against Ley (hu3S193) and A33 (huA33) which can target cancer cells. We aim to develop optimal cancer cell killing by our antibodies.
Funding Amount $AUD 807,029.14
Funding Scheme Project Grants
Notes Standard Project Grant
- nhmrc : 1030469
- PURL : https://purl.org/au-research/grants/nhmrc/1030469